샘플 요청 목록

 카트 문의
시장보고서
상품코드
1536158

세계 감염성 장염 치료 시장

Infectious Enteritis Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

감염성 장염 치료 세계 시장은 2030년까지 6억 2,280만 달러에 달할 전망

2023년에 4억 4,000만 달러로 추정되는 감염성 장염 치료 세계 시장은 2023-2030년간 CAGR 5.1%로 성장하여 2030년에는 6억 2,280만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 항생제는 CAGR 5.7%로 성장을 지속하고, 분석 기간 종료 시 3억 5,320만 달러에 달할 것으로 예측됩니다. 항바이러스제 부문의 성장률은 분석 기간 동안 CAGR 4.4%로 추정됩니다.

미국 시장은 1억 1,990만 달러로 추정, 중국은 CAGR 8.4%로 성장 예측

미국의 감염성 장염 치료 시장은 2023년 1억 1,990만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 1억 3,020만 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 8.4%입니다. 기타 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.0%와 5.3%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.1%로 성장할 것으로 예측됩니다.

세계 감염성 장염 치료 시장 - 주요 동향 및 촉진요인 요약

감염성 장염은 박테리아, 바이러스 및 기생충을 포함한 다양한 병원체에 의해 유발되는 장의 염증입니다. 일반적인 원인으로는 로타바이러스, 노로바이러스, 대장균, 살모넬라균 등을 들 수 있으며, 설사, 복통, 구토, 발열 등의 증상을 일으킵니다. 감염 경로는 일반적으로 오염된 음식과 물을 섭취하거나 감염된 사람과 직접 접촉하는 것입니다. 감염성 장염의 치료는 증상의 중증도와 감염된 병원체에 따라 다릅니다. 바이러스 감염의 경우 항생제가 효과가 없으므로 일반적으로 수분 공급과 전해질 균형에 중점을 둔 지지 요법이 수행됩니다. 박테리아 감염이나 기생충 감염의 경우, 대변 검사 및 기타 진단 방법으로 확인된 병원체에 따라 특정 항균제가 처방됩니다. 어떠한 경우에도 수분 공급을 유지하는 것이 중요하며, 특히 유아 및 노인과 같은 취약한 집단의 경우 심각한 탈수 위험이 높습니다.

감염성 장염을 관리하는 접근법은 진단 도구와 치료 전략의 진보와 함께 진화해 왔습니다. 신속 진단 검사가 점점 더 이용 가능 해지고 원인균의 신속한 식별과 적절한 관리의 조기 개시가 가능하게 되었습니다. 이는 지역 환경 및 집단 발생 시 감염 확대를 막는 데 특히 중요합니다. 게다가 장염의 치료와 예방을 위한 가이드라인의 책정과 보급에도 큰 진전이 있어, 로타바이러스에 대한 백신 등, 이용 가능한 경우에는 그 사용을 추천하고 있습니다. 수질 개선, 손가락 위생 촉진, 안전한 식품 취급 방법 교육에 중점을 둔 공중 보건 활동도 전 세계 감염성 장염 발생률 감소에 중요한 역할을 하고 있습니다.

감염성 장염 치료 시장의 성장은 세계 인구 증가, 질병에 대한 인식 증가, 치료 및 진단 기술의 진보 등 여러 요인에 의해 초래됩니다. 세계 인구가 증가함에 따라, 특히 개발 도상 지역에서는 위생 환경, 깨끗한 물 접근, 공중 보건 인프라의 과제로 장관 감염의 부담이 증가하고 있습니다. 이 때문에 예방 대책과 효과적인 치료 모두에 대한 수요가 높아지고 있습니다. 유전체 및 분자진단 기술의 진보는 보다 신속하고 정확한 병원체의 확인을 가능하게 하고, 따라서 표적 요법의 개발을 지원합니다. 또한 백신과 공중 보건 교육을 통한 질병 예방의 중요성에 대한 의식이 커지면서 시장 성장에 기여하고 있습니다. 소비자의 행동은 수분 보급액과 프로바이오틱스 등 보다 신속하고 효과적인 치료를 요구하는 방향으로 이동하고 있으며, 이들은 장 건강을 지원하는 이점이 인정되어 인기를 끌고 있습니다. 이러한 움직임은 감염성 장염의 치료에서 혁신적이고 효과적인 솔루션에 대한 수요가 견조하게 변화하고 있음을 보여줍니다.

조사 대상 기업 예(전 86건)

  • AdvaCare Pharma
  • Astellas Pharma, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Centurion Healthcare Private Limited
  • Merck & Co., Inc.
  • Tokushukai Medical Group

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.08.29

Global Infectious Enteritis Treatment Market to Reach US$622.8 Million by 2030

The global market for Infectious Enteritis Treatment estimated at US$440.0 Million in the year 2023, is expected to reach US$622.8 Million by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$353.2 Million by the end of the analysis period. Growth in the Antiviral Drugs segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$119.9 Million While China is Forecast to Grow at 8.4% CAGR

The Infectious Enteritis Treatment market in the U.S. is estimated at US$119.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$130.2 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Infectious Enteritis Treatment Market - Key Trends and Drivers Summarized

Infectious enteritis is an inflammation of the intestines caused by a variety of pathogens, including bacteria, viruses, and parasites. Common culprits include rotavirus, norovirus, Escherichia coli, and Salmonella, which can lead to symptoms such as diarrhea, abdominal pain, vomiting, and fever. The disease transmission typically occurs through consumption of contaminated food or water, or direct contact with infected individuals. Treatment for infectious enteritis depends on the severity of the symptoms and the specific pathogen involved. For viral infections, management is generally supportive, focusing on hydration and electrolyte balance, as antibiotics are not effective. For bacterial or parasitic infections, specific antimicrobials are prescribed based on the organism identified through stool tests or other diagnostic methods. In all cases, maintaining hydration is critical, especially for vulnerable populations such as young children and the elderly, who are at higher risk of severe dehydration.

The approach to managing infectious enteritis has evolved with advances in diagnostic tools and treatment strategies. Rapid diagnostic tests have become increasingly available, enabling quicker identification of the causative agent and appropriate management to be initiated sooner. This is particularly important in preventing the spread of infections in community settings and during outbreaks. Furthermore, there has been significant progress in developing and disseminating guidelines for the treatment and prevention of enteritis, including recommendations for the use of vaccines where available, such as those against rotavirus. Public health initiatives focusing on improving water quality, promoting hand hygiene, and educating about safe food handling practices also play a crucial role in reducing the incidence of infectious enteritis globally.

The growth in the infectious enteritis treatment market is driven by several factors, including global population growth, increased awareness of the disease, and advancements in medical treatments and diagnostic technologies. As the global population increases, particularly in developing regions, there is a higher burden of enteric infections due to challenges in sanitation, clean water access, and public health infrastructure. This drives demand for both preventive measures and effective treatments. Advancements in genomic and molecular diagnostic techniques allow for more rapid and accurate pathogen identification, which in turn supports the development of targeted therapies. Additionally, the rising awareness of the importance of disease prevention through vaccines and public health education contributes to market growth. Consumer behavior has shifted towards seeking quicker, more effective treatments, including rehydration solutions and probiotics, which are gaining popularity for their perceived benefits in supporting gut health. These dynamics indicate a robust ongoing demand for innovative and effective solutions in the treatment of infectious enteritis.

Select Competitors (Total 86 Featured) -

  • AdvaCare Pharma
  • Astellas Pharma, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Centurion Healthcare Private Limited
  • Merck & Co., Inc.
  • Tokushukai Medical Group

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Infectious Enteritis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidences of Infectious Enteritis Drive Urgency for Effective Treatment Solutions
    • Advances in Microbiome Research Strengthen Business Case for Targeted Enteritis Therapies
    • Growth in Travel and Exposure to Novel Pathogens Sets the Stage for Broader Enteritis Treatment Needs
    • Development of Rapid Diagnostic Tests for Enteric Pathogens Enhances Treatment Efficiency
    • Growing Focus on Pediatric and Elderly Populations Drives Specialized Treatment Approaches
    • Consumer Preferences for Alternative and Herbal Medicines Impact Traditional Treatment Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Infectious Enteritis Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Infectious Enteritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Antiviral Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injectables Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injectables Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Injectables Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • JAPAN
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • CHINA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • EUROPE
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Infectious Enteritis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • FRANCE
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • GERMANY
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Infectious Enteritis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • INDIA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Infectious Enteritis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Infectious Enteritis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Infectious Enteritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030
  • AFRICA
    • Infectious Enteritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Infectious Enteritis Treatment by Drug Type - Antibiotics, Antiviral Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Infectious Enteritis Treatment by Drug Type - Percentage Breakdown of Value Sales for Antibiotics, Antiviral Drugs and Other Drug Types for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Infectious Enteritis Treatment by Route Of Administration - Oral Administration and Injectables Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Infectious Enteritis Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Injectables Administration for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제